Miroshnik, D. M. (2020). Use of combined nucleotide drug in treatment of ophthalmic manifestations of Sjogren's disease.
Chicago-Zitierstil (17. Ausg.)Miroshnik, D. M. Use of Combined Nucleotide Drug in Treatment of Ophthalmic Manifestations of Sjogren's Disease. 2020.
MLA-Zitierstil (8. Ausg.)Miroshnik, D. M. Use of Combined Nucleotide Drug in Treatment of Ophthalmic Manifestations of Sjogren's Disease. 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.